Antiarrhythmic activity of TR 2985, a novel diphenylhydantoin derivative.
D000779:Anesthetics, Local; D000818:Animals; D000889:Anti-Arrhythmia Agents; D001001:Anura; D003331:Coronary Vessels / Q000502:physiology; D004285:Dogs; D004558:Electric Stimulation; D005260:Female; D006168:Guinea Pigs; D006321:Heart / Q000502:physiology; D006439:Hemodynamics / Q000187:drug effects; D066298:In Vitro Techniques; D008012:Lidocaine / Q000494:pharmacology; D008297:Male; D051379:Mice; D010042:Ouabain / Q000494:pharmacology; D010672:Phenytoin / Q000031:analogs & derivatives* / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011802:Quinidine / Q000494:pharmacology
D000779:Anesthetics, Local; D000889:Anti-Arrhythmia Agents; D010042:Ouabain; D010672:Phenytoin; C024222:ropitoin hydrochloride; D008012:Lidocaine; D011433:Propranolol; D011802:Quinidine